Hill City Capital
Boston, Massachusettscityhill.com
Overview
Hill City Capital is a US-based investment adviser registered with the SEC. The firm operates as a hedge fund manager employing a long/short equity strategy and also makes private equity and venture capital investments in various sectors, including healthcare and biotechnology. It manages pooled investment vehicles for its clients.
Portfolio Companies
4
Website
cityhill.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| SafeRide Health | Oct 2023 | Series C | Co-investor |
| Boundless Bio | May 2023 | Series C | Co-investor |
| Maze Therapeutics | Jan 2022 | Series C | Co-investor |
| OncoMyx Therapeutics | Dec 2021 | Series B | Co-investor |
| SafeRide Health | Nov 2021 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
